Figure 3
From: Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
Effect of rEpo on proliferation rate of tumour cells. Sections were taken from (A) CT-26, (B) R3230, (C) FaDu, and (D) HCT-116 tumours and stained for Ki-67. There was no statistical difference between the mean proliferation index of the rEpo-treated group and that of the control-treated group in any tumour model (P=0.14, 0.23, 0.09, and 0.11, respectively).
